Competitive, reversible cGMP-dependent protein kinase (PKG) inhibitor; cGMP analog. This product is sold in units of 560μg, equivalent to 1μmol.. Purity 99%. MW (observed): 562.27
Size
560 ug
Concentration
n/a
Applications
n/a
Other Names
2-Bromo-3,4-dihydro-3-[3,5-O-[(R)-mercaptophosphinylidene]-β-D-ribofuranosyl]-6-phenyl-9H-Imidazo[1,2-a]purin-9-one sodium salt